Naked Sendai virus vector lacking all of the envelope-related genes: Reduced cytopathogenicity and immunogenicity

Journal of Gene Medicine

Volumn 8, Issue 9, 2006, Pages 1151-1159

  Yoshizaki, Mariko ^a   Hironaka, Takashi ^a   Iwasaki, Hitoshi ^a   Ban, Hiroshi ^a   Tokusumi, Yumiko ^a   Iida, Akihiro ^a   Nagai, Yoshiyuki ^b   Hasegawa, Mamoru ^a   Inoue, Makoto ^a  

^a University of Tokyo   (Japan)

^b RIKEN   (Japan)

Author keywords

Cytoplasmic RNA vector; Gene deletion; Gene therapy; Genotoxicity free; Reduced cytotoxicity; Sendai virus

Indexed keywords

AMINO ACID; GREEN FLUORESCENT PROTEIN; HN PROTEIN; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANTIBODY TITER; ARTICLE; CELL COUNT; CELL LINE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA MODIFICATION; DNA PACKAGING; EX VIVO STUDY; FUSION GENE; GENE DELETION; GENE MUTATION; GENETIC TRANSDUCTION; GENOME ANALYSIS; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; MONKEY; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RNA VECTOR; SAFETY; SENDAI VIRUS; VIRAL GENE THERAPY; VIRUS GENOME; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CELL LINE; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; GENE DELETION; GENE EXPRESSION; GENE THERAPY; GENES, ENV; GENES, VIRAL; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HAPLORHINI; HN PROTEIN; MUTATION; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; SENDAI VIRUS; VIRAL FUSION PROTEINS; VIRAL MATRIX PROTEINS; VIRUS ASSEMBLY;

MAMMALIA; SENDAI VIRUS;

EID: 33749255210     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.938     Document Type: Article

References (29)

1. Lamb RA, Kolakofsky D. Paramyxoviridae: the viruses and their replication. In Fields Virology, Fields BN, Knipe DM, Howley PM (eds). Lippincott-Raven: Philadelphia, 1996; 1177-1204.
2. Bitzer M, Armeanu S, Lauer UM, et al. Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med 2003; 5: 543-553.
3. Griesenbach U, Inoue M, Hasegawa M, et al. Sendai virus for gene therapy and vaccination. Curr Opin Mol Ther 2005; 7: 346-352.
4. Masaki I, Yonemitsu Y, Yamashita A, et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002; 90: 966-973.
5. Shoji T, Yonemitsu Y, Komori K, et al. Intramuscular gene transfer of FGF-2 attenuates endothelial dysfunction and inhibits intimal hyperplasia of vein grafts in poor-runoff limbs of rabbit. Am J Physiol Heart Circ Physiol 2003; 285: H173-182.
6. Iwadate Y, Inoue M, Saegusa T, et al. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats. Clin Cancer Res 2005; 11: 3821-3827.
7. Kinoh H, Inoue M, Washizawa K, et al. Generation of a recombinant Sendai virus that is selectively activated and lyses human rumor cells expressing matrix metalloproteinases. Gene Ther 2004; 11: 1137-1145.
8. Matano T, Kobayashi M, Igarashi H, et al. Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. J Exp Med 2004; 199: 1709-1718.
9. Takeda A, Igarashi H, Nakamura H, et al. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J Virol 2003; 77: 9710-9715.
10. Morrison T, McQuain C, McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol 1991; 65: 813-822.
11. Arnon TI, Lev M, Katz G, et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30. Eur J Immunol 2001; 31: 2680-2689.
12. Guertin DP, Fan DP. Stimulation of cytolytic T cells by isolated viral peptides and HN protein coupled to agarose beads. Nature 1980; 283: 308-311.
13. Justice PA, Sun W, Li Y, et al. Membrane vesiculation function and exocytosis of wild-type and mutant matrix proteins of vesicular stomatitis virus. J Virol 1995; 69: 3156-3160.
14. Mebatsion T, Konig M, Conzelmann KK. Budding of rabies virus particles in the absence of the spike glycoprotein. Cell 1996; 84: 941-951.
15. Li H-O, Zhu YF, Asakawa M, et al. A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol 2000; 74: 6564-6569.
16. Inoue M, Tokusumi Y, Ban H, et al. A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J Virol 2003; 77: 6419-6429.
17. Inoue M, Tokusumi Y, Ban H, et al. Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable properties. J Gene Med 2004; 6: 1069-1081.
18. Inoue M, Tokusumi Y, Ban H, et al. Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J Virol 2003; 77: 3238-3246.
19. Bernloehr C, Bossow S, Ungerechts G, et al. Efficient propagation of single gene deleted recombinant Sendai virus vectors. Virus Res 2004; 99: 193-197.
20. Hamaguchi M, Yoshida T, Nishikawa K, et al. Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 1983; 128: 105-117.
21. Kanegae Y, Takamori K, Sato Y, et al. Efficient gene activation system on mammalian cell chromosomes using recombinant adenovirus producing Cre recombinase. Gene 1996; 181: 207-212.
22. Arai T, Matsumoto K, Saitoh K, et al. A new system for stringent, high-titer vesicular stomatitis virus G protein-pseudotyped retrovirus vector induction by introduction of Cre recombinase into stable prepackaging cell lines. J Virol 1998; 72: 1115-1121.
23. Segawa H, Kato M, Yamashita T, et al. The roles of individual cysteine residues of Sendai virus fusion protein in intracellular transport. J Biochem (Tokyo) 1998; 123: 1064-1072.
24. Miura N, Uchida T, Okada Y. HVJ (Sendai virus)-induced envelope fusion and cell fusion are blocked by monoclonal anti-HN protein antibody that does not inhibit hemagglutination activity of HVJ. Exp Cell Res 1982; 141: 409-420.
25. Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988; 115: 61-69.
26. Kato A, Sakai Y, Shioda T, et al. Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1996; 1: 569-579.
27. Bossow S, Neubert WJ. A set of four mutations in the P and L genes derived from persistent Sendai virus variants attenuates viral replication. Negative Strand Viruses 2000; 157.
28. Ogino T, Iwama M, Ohsawa Y, et al. Interaction of cellular tubulin with Sendai virus M protein regulates transcription of viral genome. Biochem Biophys Res Commun 2003; 311: 283-293.
29. Tozawa H, Komatsu H, Ohkata K, et al. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus. Arch Virol 1986; 91: 145-161.